299 related articles for article (PubMed ID: 26956418)
21. Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage.
Michels M; Japtok L; Alisjahbana B; Wisaksana R; Sumardi U; Puspita M; Kleuser B; de Mast Q; van der Ven AJ
J Infect; 2015 Oct; 71(4):480-7. PubMed ID: 26183296
[TBL] [Abstract][Full Text] [Related]
22. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.
Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice.
Kurano M; Tsuneyama K; Morimoto Y; Nishikawa M; Yatomi Y
FASEB J; 2019 Apr; 33(4):5181-5195. PubMed ID: 30629456
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein M/sphingosine 1-phosphate protects against diabetic nephropathy.
Kurano M; Tsukamoto K; Shimizu T; Hara M; Yatomi Y
Transl Res; 2023 Aug; 258():16-34. PubMed ID: 36805561
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis.
Mathiesen Janiurek M; Soylu-Kucharz R; Christoffersen C; Kucharz K; Lauritzen M
Elife; 2019 Nov; 8():. PubMed ID: 31763978
[TBL] [Abstract][Full Text] [Related]
27. Effects of apolipoprotein M in uremic atherosclerosis.
Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
[TBL] [Abstract][Full Text] [Related]
28. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity.
Kurano M; Ikeda H; Iso-O N; Hara M; Tsukamoto K; Yatomi Y
Biochem J; 2018 Jun; 475(12):2009-2024. PubMed ID: 29712716
[TBL] [Abstract][Full Text] [Related]
31. Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis.
Li Y; Zhou J; Qiu J; Huang Z; Wang W; Wu P; Feng A
Life Sci; 2020 Nov; 261():118460. PubMed ID: 32961234
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system.
Yao Mattisson I; Christoffersen C
Atherosclerosis; 2021 Oct; 334():76-84. PubMed ID: 34482091
[TBL] [Abstract][Full Text] [Related]
33. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.
Kurano M; Tsukamoto K; Hara M; Ohkawa R; Ikeda H; Yatomi Y
J Biol Chem; 2015 Jan; 290(4):2477-88. PubMed ID: 25505264
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein M bound sphingosine 1-phosphate suppresses NETosis through activating S1P1 and S1P4.
Kurano M; Uranbileg B; Yatomi Y
Biomed Pharmacother; 2023 Oct; 166():115400. PubMed ID: 37657263
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.
Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ
Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189
[TBL] [Abstract][Full Text] [Related]
36. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
Yafasova A; Mandrup CM; Egelund J; Nyberg M; Stallknecht B; Hellsten Y; Nielsen LB; Christoffersen C
J Appl Physiol (1985); 2019 Jan; 126(1):214-220. PubMed ID: 30433864
[TBL] [Abstract][Full Text] [Related]
37. The Apolipoprotein M/S1P Axis Controls Triglyceride Metabolism and Brown Fat Activity.
Christoffersen C; Federspiel CK; Borup A; Christensen PM; Madsen AN; Heine M; Nielsen CH; Kjaer A; Holst B; Heeren J; Nielsen LB
Cell Rep; 2018 Jan; 22(1):175-188. PubMed ID: 29298420
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury.
Kurano M; Tsuneyama K; Morimoto Y; Shimizu T; Jona M; Kassai H; Nakao K; Aiba A; Yatomi Y
Thromb Haemost; 2018 Jun; 118(6):1021-1035. PubMed ID: 29669385
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
Whetzel AM; Bolick DT; Srinivasan S; Macdonald TL; Morris MA; Ley K; Hedrick CC
Circ Res; 2006 Sep; 99(7):731-9. PubMed ID: 16960101
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes.
Christensen PM; Bosteen MH; Hajny S; Nielsen LB; Christoffersen C
Sci Rep; 2017 Nov; 7(1):14983. PubMed ID: 29118354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
